Johji Imura Selected Research

ErbB Receptors (EGF Receptor)

1/2014	Analysis of KRAS mutations in cases of metastatic colorectal cancer at a single institution in Tochigi, Japan.
2/2003	Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johji Imura Research Topics

Disease

25	Neoplasms (Cancer) 08/2022 - 11/2002
8	Inflammation (Inflammations) 01/2020 - 08/2003
8	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2004
8	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 05/2002
7	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2003
6	Ulcerative Colitis 06/2014 - 03/2010
5	Carcinogenesis 08/2019 - 01/2008
5	Colonic Neoplasms (Colon Cancer) 11/2017 - 03/2010
5	Carcinoma (Carcinomatosis) 05/2014 - 01/2002
4	Lymphatic Metastasis 01/2022 - 05/2005
4	Obesity 01/2021 - 01/2012
4	Adenocarcinoma 01/2020 - 08/2007
4	Polyps 01/2015 - 01/2013
3	Adenoma (Adenomas) 08/2022 - 01/2013
3	Insulin Resistance 01/2020 - 01/2012
3	Fibrosis (Cirrhosis) 12/2016 - 09/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2016 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 07/2009 - 01/2004
2	Amyloidosis 01/2021 - 01/2021
2	Rheumatoid Arthritis 01/2021 - 05/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020 - 03/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2018 - 09/2010
2	Type 2 Diabetes Mellitus (MODY) 11/2016 - 09/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2015 - 09/2010
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2014 - 03/2010
2	Colitis 11/2013 - 02/2008
2	Esophageal Neoplasms (Esophageal Cancer) 02/2006 - 08/2003
1	Melanoma (Melanoma, Malignant) 01/2022
1	Choledocholithiasis 04/2021
1	Pancreatitis 02/2021
1	Amyloid Plaque 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2021
1	Dermatomyositis (Dermatopolymyositis) 01/2021
1	Glucose Intolerance 01/2020
1	Necrosis 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2018

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
3	Keratins (Keratin)IBA 08/2022 - 11/2002
3	Biological ProductsIBA 02/2022 - 09/2020
3	CytokinesIBA 09/2020 - 03/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2007
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
3	Cadherins (E-Cadherin)IBA 11/2017 - 05/2005
3	CateninsIBA 11/2017 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 08/2012
3	MucinsIBA 05/2014 - 11/2002
3	Calcibiotic Root Canal SealerIBA 06/2013 - 02/2003
3	Tyrosine (L-Tyrosine)FDA Link 05/2011 - 02/2003
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2008 - 10/2005
3	VimentinIBA 10/2007 - 11/2004
2	Indicators and Reagents (Reagents)IBA 02/2022 - 08/2014
2	KalininIBA 01/2021 - 08/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2020
2	CyclinsIBA 02/2020 - 12/2003
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2014
2	Tumor Biomarkers (Tumor Markers)IBA 11/2016 - 08/2007
2	AntigensIBA 11/2016 - 05/2015
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 08/2016 - 06/2014
2	Peptides (Polypeptides)IBA 07/2015 - 05/2015
2	Gefitinib (Iressa)FDA Link 07/2015 - 09/2010
2	EpitopesIBA 05/2015 - 08/2014
2	Monoclonal AntibodiesIBA 05/2015 - 08/2014
2	Sodium Glutamate (Accent)IBA 09/2014 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2014 - 02/2003
2	DesminIBA 06/2013 - 01/2005
2	Interleukin-22 (IL-22)IBA 05/2011 - 03/2010
2	InterleukinsIBA 03/2010 - 01/2008
2	CAM 5.2 antigenIBA 08/2007 - 11/2004
1	Perilipin-2IBA 08/2022
1	Differentiation AntigensIBA 01/2022
1	Potassium PermanganateIBA 01/2021
1	NivolumabIBA 01/2021
1	Prealbumin (Transthyretin)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	AA amyloidosisIBA 01/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2020
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 02/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020
1	lenvatinibIBA 01/2020
1	HemosiderinIBA 01/2020
1	astaxanthine (astaxanthin)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	AntioxidantsIBA 01/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2020
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 08/2019
1	AutoantibodiesIBA 10/2018
1	SS-A antibodiesIBA 10/2018

Therapy/Procedure

2	Pancreatectomy 02/2021 - 10/2011
2	Therapeutics 11/2017 - 01/2015
2	Hepatectomy 06/2014 - 01/2007
2	Colectomy 05/2014 - 01/2007
1	Cholecystectomy 04/2021
1	Aftercare (After-Treatment) 01/2020
1	Chemoradiotherapy 01/2020
1	Radiotherapy 01/2020